Concepedia

Author

Donn C. Young

The Ohio State University

Also Known As

D C Young, D Young, D. C. Young, D. Young, DONN C. YOUNG, DONN YOUNG, Donn C Young, Donn C. Young, Donn Young

163

Publications

7.4K

Citations

45

H-Index

143

Concepts

All Affiliations

The Ohio State UniversityThe Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research InstituteThe Ohio State University Wexner Medical CenterNational Cancer Institute
DC

About

Donn C. Young is an author at The Ohio State University specializing in medicine, oncology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

30

49

2.8K

2

Health Sciences

10

10

356

3

Engineering

2

2

74

4

Public Health

1

1

73

5

Allergy

1

1

13

Donn C. Young

×

107

Publications

7.2K

Citations

44

H-Index

YearCitations

Psychologic intervention improves survival for breast cancer patients

Barbara L. Andersen, Hae‐Chung Yang, William B. Farrar,

Cancer

2008

487

Flavopiridol administered using a pharmacologically derived schedule is associated with marked clinical efficacy in refractory, genetically high-risk chronic lymphocytic leukemia

John C. Byrd, Thomas S. Lin, James T. Dalton,

Blood

2006

387

Methods to Improve Efficacy of Intravesical Mitomycin C: Results of a Randomized Phase III Trial

Jessie L.‐S. Au, Robert A. Badalament, M. Guillaume Wientjes,

JNCI Journal of the National Cancer Institute

2001

301

Ultraviolet Radiation-Induced Corneal Degeneration in 129 Mice

Kim M. Newkirk, Heather L. Chandler, Allison E. Parent,

Toxicologic Pathology

2007

274

Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer

William E. Burak, Scott T. Hollenbeck, Emmanuel E. Zervos,

The American Journal of Surgery

2002

235

Phase 1 and pharmacodynamic studies of G3139, a Bcl-2 antisense oligonucleotide, in combination with chemotherapy in refractory or relapsed acute leukemia

Guido Marcucci, John C. Byrd, Guowei Dai,

Blood

2002

220

FcγRIIIa and FcγRIIa polymorphisms do not predict response to rituximab in B-cell chronic lymphocytic leukemia

Sherif S. Farag, Ian W. Flinn, Rama Modali,

Blood

2003

206

Sextant prostate biopsies. A histopathologic correlation with radical prostatectomy specimens

Paul A. Peller, Donn C. Young, David P. Marmaduke,

Cancer

1995

183

Apoptotic-Regulatory and Complement-Protecting Protein Expression in Chronic Lymphocytic Leukemia: Relationship to In Vivo Rituximab Resistance

Rajat Bannerji, Shinichi Kitada, Ian W. Flinn,

Journal of Clinical Oncology

2003

177

An Algorithm for Predicting Nonorgan Confined Prostate Cancer Using the Results Obtained from Sextant Core Biopsies with Prostate Specific Antigen Level

Robert A. Badalament, Miller Craig, Paul A. Peller,

The Journal of Urology

1996

167

Page 1